What peptides these deltorphins be

被引:64
作者
Lazarus, LH
Bryant, SD
Cooper, PS
Salvadori, S
机构
[1] NIEHS, Res Triangle Pk, NC 27709 USA
[2] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[3] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
关键词
D O I
10.1016/S0301-0082(98)00050-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The deltorphins are a class of highly selective delta-opioid heptapeptides from the skin of the Amazonian frogs Phyllomedusa sauvagei and P, bicolor. The first of these fascinating peptides came to light in 1987 by cloning of the cDNA of from frog skins, while the other members of this family were identified either by cDNA or isolation of the peptides. The distinctive feature of deltorphins is the presence of a naturally occurring D-enantiomer at the second position in their common N-terminal sequence, Tyr-D-Xaa-Phe, comparable to dermorphin, which is the prototype of a group of mu-selective opioids from the same source. The D-amino acid and the anionic residues, either Glu or Asp, as well as their unique amino acid compositions are responsible for the remarkable biostability, high delta-receptor affinity, bioactivity and peptide conformation. This review summarizes a decade of research from many laboratories that defined which residues and substituents in the deltorphins interact with the delta-receptor and characterized pharmacological and physiological activities in vitro and in vivo. It begins with a historical description of the topic and presents general schema for the synthesis of peptide analogues of deltorphins A, B and C as a means to document the methods employed in producing a myriad of analogues. Structure-activity studies of the peptides and their pharmacological activities in vitro are detailed in abundantly tabulated data. A brief compendium of the current level of knowledge of the delta-receptor assists the reader to appreciate the rationale for the design of these analogues. Discussion of the conformation of these peptides addresses how structure leads to further hypotheses regarding ligand-receptor interaction. The review ends with a broad discussion of the potential applications of these peptides in clinical and therapeutic settings. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:377 / 420
页数:44
相关论文
共 407 条
[1]   PRODUCTION OF ANTISERUM TO [D-ALA2]DELTORPHIN I AND ITS IMMUNOHISTOCHEMICAL APPLICATION TO THE MOUSE-BRAIN [J].
ABE, H ;
TOOYAMA, I ;
RENDA, T ;
ERSPARMER, V ;
KIMURA, H .
NEUROREPORT, 1992, 3 (08) :669-672
[2]   A 3D model of the delta opioid receptor and ligand-receptor complexes [J].
Alkorta, I ;
Loew, GH .
PROTEIN ENGINEERING, 1996, 9 (07) :573-583
[3]  
AMICHE M, 1989, MOL PHARMACOL, V35, P774
[4]  
AMODEO P, 1992, PEPTIDE RES, V5, P48
[5]  
Amodeo P, 1998, J PEPT RES, V51, P180
[6]  
ARDEN JR, 1995, J NEUROCHEM, V65, P1636
[7]   Role of activation of calcium-sensitive K+ channels and cAMP in opioid-induced pial artery dilation [J].
Armstead, WM .
BRAIN RESEARCH, 1997, 747 (02) :252-258
[8]  
ATTILA M, 1993, INT J PEPT PROT RES, V42, P550
[9]  
ATTILA M, 1994, CAN J PHYSL S1, V72, pS26
[10]   NEW FEATURES OF THE DELTA-OPIOID RECEPTOR - CONFORMATIONAL PROPERTIES OF DELTORPHIN-I ANALOGS [J].
BALBONI, G ;
MARASTONI, M ;
PICONE, D ;
SALVADORI, S ;
TANCREDI, T ;
TEMUSSI, PA ;
TOMATIS, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (02) :617-622